Life Science Investing Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer's Disease 12 December
Life Science Investing Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer's Disease Conference 26 November
Life Science Investing Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update 25 November
